E. A. J. K, R. J.  S, J. P. M.  D, P. R. S  R. G. S. Chronic Aspirin Treatment Affects Collagen Deposition in Non-infarcted Myocardium During Remodeling after Coronary Artery Ligation in the Rat. Journal of Molecular and Cellular Cardiology (1995) 27, 2483-2494. Low-dose aspirin (acetylsalicylic acid; ASA), inhibiting platelet thromboxane production in favor of endothelium formation of prostaglandins, is successfully used as primary or secondary prophylaxis against myocardial infarction. Although prognosis may be improved, effects of long-term ASA treatment on wound healing and cardiac remodeling are not well understood. The aim of the present study was to mimic the clinical situation by inducing myocardial infarction in low-dose ASA (25 mg/kg/day, i.p.) pretreated rats, and to determine effects on plasma eicosanoid levels, cardiac hypertrophy and collagen deposition, and left ventricular function during continued ASA treatment. The effects of this dose were verified to selectively inhibit platelet thromboxane production, and lower plasma levels of thromboxane, but did not affect plasma levels of prostacyclin and prostaglandin E 2 during the acute inflammatory stage following myocardial infarction. As measured by heart dry weight/body weight, cardiac hypertrophy was not affected by ASA treatment. However, interstitial fibrosis in the spared myocardium as well as perivascular fibrosis, associated with infarction-induced cardiac remodeling, were affected by ASA treatment. Replacement fibrosis in the infarct itself, considered as representing wound healing, was not significantly influenced by ASA treatment. Wall thinning following infarction was not aggravated, nor did treatment influence left ventricular cavity diameter in a relaxed state. Results from in vitro left ventricular function measurements showed no effects on left ventricular peak velocity of contraction or relaxation after ASA treatment. In conclusion, although low-dose ASA may not be expected to have anti-inflammatory action, it did influence post-infarct cardiac remodeling by affecting interstitial and perivascular fibrosis. ASA treatment did not have effects on in vitro left ventricular dysfunction.
Introduction
glandins (Patrignani et al., 1982; Coller, 1991) . ASA improves prognosis and reduces the chance Low-dose aspirin (acetylsalicylic acid, ASA) treatment is used in coronary artery disease as primary of re-infarction after myocardial infarction (ISIS-2 Collaborative Group, 1988) , and this effect can be or secondary prophylaxis against myocardial infarction, as it reduces platelet production of proattributed to its anti-platelet action (Antiplatelet Trialists ' Collaboration, 1988) . aggregatory and vasoconstrictor thromboxane in At higher doses, ASA can also exert antiValidation of the used dose of aspirin inflammatory activity by interference with the synthesis of prostaglandins. Anti-inflammatory To confirm the selectivity of chronic aspirin treatment as inhibiting platelet versus vascular cyclotreatment with corticosteroids and non-steroid anti-inflammatory drugs (NSAIDs) has been shown oxygenase activity, a separate group of rats was treated with either ASA 25 mg/kg body weight (n= to retard collagen deposition and to cause infarct thinning (Bulkley and Roberts, 1974 ; Kloner et 6) (based on pilot short-term dose-finding studies) or saline (n=6) as daily i.p. injection. Following 3 al., 1978; Brown et al., 1983; Hammerman et al., 1983a,b; Mannisi et al., 1987; Vivaldi et al., weeks of treatment, blood was sampled by heart puncture under pentobarbital (60 mg/kg) an-1987; Jugdutt and Basualdo, 1989) . These studies focused on the replacement fibrosis that results esthesia, 24 h after the last dose of ASA. Native blood (1 ml) was allowed to clot in a Vacutainer ® in scar formation, whereas effects on interstitial fibrosis that occurs in remote, non-infarcted areas glass tube containing SST ® Gel and Clot Activator (Becton Dickinson, Meylan Cedex, France) at room (van Krimpen et al., 1991) are still unknown. Moreover, whether scar formation and cardiac temperature for 30 min. Serum was separated by centrifugation and, after Sep Pak (Millipore, Milford, fibrosis in spared myocardium would be affected in patients pretreated followed by continued treat-USA) extraction, stored at −20°C in methanol until assayed for thromboxane B 2 (TxB 2 ) produced. ment with low-dose ASA, which seems to be devoid of anti-inflammatory action, remains to be A 2 mm-long segment was isolated from the thoracic aorta. The segments were incubated at determined.
The present study was carried out to address this 37°C for 10 min in 200 l of Krebs-Henseleit buffer containing 25  arachidonic acid (Supelco, Bellequestion in a rat model of myocardial infarction (Fishbein et al., 1978) . A dose of ASA that inhibits fonte). The rings were removed and weighed, and the supernatant passed through Sep Pak filters and thromboxane production from platelets but does not interfere with prostacyclin production from stored at −20°C in methanol until assayed for 6-keto-PGF 1 generation, which was expressed as ng/ endothelial cells, was carefully selected as a treatment reflecting the aims of low-dose aspirin treatmg wet tissue of aortic segment. ment in man. Plasma eicosanoid levels were evaluated at different time points. The effects on interstitial and perivascular fibrosis in spared myocardium, on replacement fibrosis in the infarcted area were investigated, as well as on cardiac reSurgical preparation modeling parameters and left ventricular function in vitro.
Under pentobarbital (60 mg/kg, i.p.) anesthesia, a PE-10 catheter filled with heparinized saline (50 IU/ml) was introduced into the thoracic aorta via the left carotid artery. The catheter was guided subcutaneously to the neck, where it was fixed and exteriorized. Left anterior descending coronary
Methods and Materials
artery ligation was performed as described in detail elsewhere (Fishbein et al., 1978; Pfeffer et al., 1979; Male, Wistar rats (270-320 g, Harlan Zeist, The Netherlands) were used in this study. Saline or ASA Schoemaker et al., 1991) . Briefly, after the trachea was intubated, an incision was made in the skin 25 mg/kg (lysine-acetylsalicylic acid, Aspégic ® , Lorex B.V., Maarssen, The Netherlands) dissolved in overlying the fourth intercostal space, while the overlying muscles were separated and kept aside. saline was administered as daily i.p. injections of 1 ml/kg, starting 2 days before surgery, and the The animals were put on positive pressure ventilation (frequency 65/min, tidal volume 3 ml), and treatment continued until the end of the experiment, at 8, 14 or 21 days after surgery. The the thoracic cavity was opened by cutting the intercostal muscles. The heart was left in situ and injections were administered at the same time each day except on the day of surgery, when the animals a 6-0 silk suture was looped under the left coronary artery near the origin of the pulmonary artery. The were injected immediately after the operation. Rats were housed at a 12 h light/dark cycle with standsuture was tied except in sham operation. Ribs were pulled together with 3-0 silk. Subsequently, the ard rat chow and water available ad libitum. The experiments were approved by the University ethics muscles were returned to their normal position, and the skin was sutured. committee for the use of experimental animals.
Blood sampling and measurement of eicosanoids
to stabilize for at least 20 min. Left ventricular pressure tracings were recorded at high paper speed On four occasions, 1 ml blood was sampled using (100 mm/s) for graphical determination of positive and negative dP/dt max . At the end of the experiment, syringes filled with 10 l 0.1  disodium ethylenedinitrilotetra-acetic acid (EDTA): immediately hearts were arrested in diastole with a 1  KCl injection into the perfusing fluid, and prepared for after implanting the aortic catheter, but before opening the thoracic cavity (day 0), 1 day after measurement of infarct size. surgery, and 8 and 21 days after surgery, when it was obtained by aortic puncture. Day 1 was chosen as a point in time representative of acute inInfarct size measurement flammation following infarction and day 8 because it represents chronic inflammation, just after peak Large vessels and atria were removed from the heart, and the right and left ventricles were sepinfiltration of chronic inflammatory cells, and day 21 because inflammation has waned (Fishbein et arated and weighed. The left ventricle was quickly frozen (−80°C) and cut into slices of 1 mm from al., 1978).
After centrifugation, the plasma was passed apex to base. The slices were stained with nitro blue tetrazolium (NBT) according to Leprán et al. through Sep Pak C18 cartridges (Waters Ass., USA) and eluted with methanol. Samples were stored at (1983) . Briefly, the slices were incubated in 1 mg/ ml NBT in 0.1  Sörensen phosphate buffer (pH= −20°C in methanol. Because of the instability of prostacyclin and thromboxane in biological fluids, 7.4) at 37°C for 15 min, and subsequently put in cold saline (0°C). This procedure stains all tissue their stabile metabolites, 6-keto-prostaglandin F 1 (6-keto-PGF 1 ) and TxB 2 , respectively, as well as that was vital at the time of death, so provides no information about the area at risk. Colour pictures prostaglandin E 2 (PGE 2 ), were measured using radioimmunoassay (antibodies: Advanced Magwere taken from the slices, and infarct size was determined by planimetry, described in detail elsenetics, USA; Standards: Sigma, USA) as described in detail by Zijlstra et al. (1992) . To allow comwhere (Schoemaker et al., 1991) . Infarct size was expressed as a percentage of left ventricular cirparison of eicosanoid levels between the three experimental groups, samples from the same time cumference, calculated as the average of infarct size of endocardial and epicardial surfaces of all point were assayed together.
slices. Minimal scar thickness as well as thickness of the mid-interventricular septum was measured in all slices containing transmural infarction. Left Measurement of left ventricular function ventricular cavity diameter in an undistended state was estimated from mean endocardial cirUnder pentobarbital anesthesia, the heart was rapidly excised and mounted for perfusion with an cumference. Thinning ratio was calculated by dividing the scar thickness by the thickness of the oxygenated modified Krebs-Henseleit buffer (Composition in m: NaCl 125, KCl 4.7, CaCl 2 1.35, interventricular septum. Left ventricular cavity diameter to mean wall thickness ratio was calculated NaHCO 3 20, NaH 2 PO 4 0.4, MgCl 2 1.0, D-glucose 10; pH=7.4; 37°C) at a constant pressure of 85 mmHg, as an index of structural left ventricular dilation (Vogt et al., 1987) . Dry weights were determined using the Langendorff technique. Heart rate was kept constant at 300 beats/min by pacing with a after drying the tissues for 3 days at 37°C. Grass stimulator (Grass Medical Instruments, Quincy, MA, USA). A water-filled, latex balloon was inserted into the left ventricle via the left atrium, Measurement of collagen content and connected to a pressure transducer (ViggoSpectramed, Oxnard, USA). Coronary flow was At 2 weeks after surgery, when a plateau in collagen content is reached in infarcted hearts (van Krimpen, measured by an in-line flow probe (Transonic Systems, Ithaca, NY, USA) placed in the tubing just 1991), the amount of interstitial and perivascular collagen was measured in a separate group of rats, before the aorta to monitor the flow of buffer passing through the probe just before entering the coronary using the method as described previously (Brilla et al., 1991; Smits et al., 1992) . Briefly, the coronary arteries. Left ventricular pressure and coronary flow were recorded with a Grass 6B Polygraph (Grass arteries were perfused with saline (Langendorff), followed by perfusion-fixation with 3.6% phosMedical Instruments, MA, USA). Left ventricular end-diastolic pressure was set to 5 mmHg by adphate-buffered formaldehyde. The atria and large vessels were removed, the ventricles weighed and justing the balloon volume and hearts were allowed cut into four slices from apex to base. These slices
Results
were fixed in formaldehyde for at least 24 h. After fixation, the slices were dehydrated and paraffin On average, surgery-related mortality was 32% (shams 21%, saline-treated infarctions 37%, asembedded. Deparaffinized 5 m thick sections were incubated for 5 min with 0.2% (wt/vol) aqueous pirin-treated infarctions 41%), and occurred mainly during the first 24 h after surgery. After exclusion phosphomolybdic acid, and subsequently incubated for 45 min with 0.1% Sirius Red F3BA (C.I.35780, of data from three aspirin-treated and five salinetreated infarcted animals because of infarct sizes Polysciences Inc., Northampton, UK) in saturated aqueous picric acid, washed for 2 min with 0.01  smaller than 20%, infarct sizes were comparable in the saline-treated and aspirin-treated infarction HCl, dehydrated, and mounted with Entellan (Merck, Darmstadt, Germany). Distribution of colgroups (Table 1 ). All infarctions were transmural and were located in the lateral (free) wall of the lagen fibers in sections examined with normal and with polarized light was similar, validating the left ventricle. quantification of collagen with normal light (Fig.  1) . In the interventricular septum, as well as in the right ventricle, interstitial collagen was determined as the picrosirius red positive area in 40 high power fields per ventricle per heart. These areas of
Validation of the used dose of aspirin myocardium did not show signs of replacement fibrosis following focal necrosis. Thus, we measured Generation of 6-keto-PGF 1 by aortic endothelium stimulated by arachidonic acid (1.35±0.22 ng/mg interstitial fibrosis as the increase of collagen volume in the interstitium between vital myocytes wet weight in saline-treated rats) was not affected by 3 weeks of ASA treatment (1.32±0.21 ng/ (Fig. 1 ). In addition, perivascular collagen of six to 10 septal resistance arteries (diameter apmg wet weight). Production of TxB 2 from platelets during blood clotting was effectively attenuated by proximately 100 m) was measured (Fig. 2) . The perivascular picrosirius red positive area was cor-ASA therapy (1.91±0.53 ng/ml serum v 5.88±0.55 ng/ml serum). Consequently, 6-ketorected for luminal area of the vessel (Brilla et al., 1991) . In order to evaluate effects on wound heal-PGF 1 to TxB 2 ratio with ASA treatment (1.07±0.30) was significantly increased compared ing in infarcted hearts, the picrosirius red positive area was also determined in the central part of the to saline-treated animals 0.24±0.03). infarct itself.
Plasma eicosanoid levels (Fig. 3) Data analysis
TxB 2 levels were significantly lowered by ASA treatment at all time points except at day 8, when no Results comprise data obtained from six to 12 animals per group. Data are expressed as group statistical significance was reached (P=0.07). TxB 2 levels appeared to be higher at 21 days compared means±... unless indicated otherwise. Rats in the sham group had measured infarct sizes of 0%.
to the other time points, but these samples were assayed separately. 6-Keto-PGF 1 levels were sigData from rats with measured infarct sizes less than 20% were excluded from analysis, because these nificantly decreased by ASA treatment at day 0 and 21, but not during inflammatory stimulation, infarcts are hemodynamically fully compensated (Schoemaker et al., 1991) . Only eicosanoid measat day 1 and 8. This resulted in a comparable presurgical 6-keto-PGF 1 to TxB 2 ratio in ASAurements of animals that survived the complete protocol were used. Because plasma eicosanoid and saline-treated rats (3.5±1.1 and 3.1±1.0, respectively), whereas this ratio was significantly levels did not show a normal distribution, median values ±95% confidence intervals are quoted, and increased in ASA-treated animals, during acute inflammation, at day 1 (16.4±4.9 v 5.0±1.7). non-parametric data analysis was performed, using the Kruskal-Wallis test. Morphological and func-
The ratio returned to presurgical levels at day 8 (3.5±0.7 v 2.5±0.6). PGE 2 levels were never tional data were analysed using one-way analysis of variance (ANOVA), followed by a post hoc affected by ASA treatment, although a tendency towards inhibition might be present after 3 weeks t-test (Wallenstein et al., 1980) . Differences were considered statistically significant if P<0.05. of treatment. Left ventricular morphology and function increased. This was the result of an increased left ventricular cavity diameter (3.2±0.2 v Heart wet weight was significantly increased at 2.4±0.1 mm) and a decreased wall thickness (3.2±0.1 v 3.7±0.1 mm) at an unchanged outer 8 days after myocardial infarction, which was mainly attributable to the left ventricle. This diameter (9.7±0.2 mm for both groups), at 21 days. These parameters were comparable in hearts observation was even more pronounced in infarcted hearts from ASA-treated rats. However, from saline-and ASA-treated animals. Scar thickness did not differ between untreated and ASAfor dry weights no differences between the experimental groups were present. Heart dry weight treated rats (1.1±0.1 v 1.2±0.1 mm at 8 days, and 1.3±0.1 v 1.5±0.2 mm at 21 days), nor was to body weight ratios did not differ between the groups (Table 1) treated rats, respectively). Thus, thinning ratio was after ASA treatment (Figs 1 and 4) . Also in right ventricular myocardium, infarcted hearts showed not influenced by ASA treatment (Table 1) .
In vitro left ventricular dysfunction of infarcted a higher interstitial collagen content, which was slightly but insignificantly reduced by ASA treathearts became evident from a depressed peak velocity of contraction and relaxation, demonstrated ment (Fig. 4) . Perivascular collagen of resistance arteries in the by a significantly depressed peak +(dP/dt) and −(dP/dt). ASA treatment delayed the development interventricular septum was significantly increased after infarction (0.96±0.09 v 0.63±0.09 piof left chamber dysfunction; contractility and relaxation were not significantly depressed until 3 crosirius red positive area/luminal area). ASA treatment significantly affected this collagen deposition weeks after infarction. A similar tendency, though less pronounced, could be seen for systolic pressure (0.71±0.05, P=0.04) (Fig. 2) . developed during Langendorff perfusion. Coronary flow in infarcted hearts was not decreased compared to sham values. However, at 8 days after surgery, coronary flow corrected for wet cardiac tissue Discussion weight, but not for dry weight, was significantly decreased in infarcted hearts after ASA treatment ASA treatment and eicosanoid profile (Table 2 ).
In the primary and secondary prophylaxis of myocardial infarction low-dose aspirin is successfully used as anti-platelet therapy because it inhibits Collagen deposition in infarcted and non-infarcted myocardium (Figs 1, 2 and 4) platelet production of thromboxane in favor of endothelium formation of prostaglandins. In this study, In the infarcted area itself, 56.0±3.3% of total firstly, we evaluated the effects of ASA treatment in normal healthy animals with regard to platelet tissue area was found picrosirius red positive, which was not significantly influenced by ASA treatment and vascular endothelium cyclo-oxygenase potential to generate thromboxane and prostacyclin, (49.4±1.0%). Non-infarcted, interventricular septum showed a considerably higher content of pirespectively. This is important because inter-species differences in sensitivity and metabolism make dose crosirius red positive material after coronary artery ligation than corresponding areas in hearts from extrapolation from animal to man on a body weight basis questionable. Corresponding to the rationale sham operated rats, which was almost normalized (Gambino et al., 1988) . The site of production of plasma prostacyclin may not be limited to vascular endothelium (Mehta et al., 1985; Vergara-Dauden et al., 1985; Weber et al., 1989) .
Prostacyclin levels during the inflammatory stage (day 1 and 8) were not affected by ASA treatment. Although inflammation did not result in higher plasma concentrations of prostacyclin, there may be a greater proportion of total release into plasma attributable to the inducible cyclooxygenase-2 (COX-2) at the expense of the constitutional cyclooxygenase-1 (COX-1) (Vane et al., 1994) . The COX-2 isoform is less sensitive to inactivation by ASA (Mitchell et al., 1993) . Plasma eicosanoid levels during this inflammatory stage showed a high interanimal variability (with no Normal distribution). Since variation of plasma eicosanoid levels rather than absolute values were increased at day 1 compared to day 0, and no differences were observed between sham and infarcted rats, we concluded that the surgical procedure rather than the infarction was responsible for the variability in plasma levels and may represent individual inflammatory responses to surgery. The variation may decline with time, indicative for acute and later waning inflammatory response.
Left ventricle morphology and in vitro function
A major finding in the present study is that lowdose ASA therapy affected collagen build-up in spared myocardium after infarction. High-dose ASA et al., 1986b) . Numerous studies have reported on * :P<0.05 v saline-treated rats.
the effects of steroids and NSAIDs on scar thickness and collagen build-up in the infarcted area (Bulkley and Roberts, 1974; Kloner et al., 1978;  Brown et behind the clinical use in man, chronic ASA treatment did not affect vascular endothelium cycloal., 1983; Hammerman et al., 1983a,b; Mannisi et al., 1987; Vivaldi et al., 1987) . Moreover, prostaoxygenase, while TxB 2 generation by platelets during blood clotting was effectively blocked. Howglandins have been implicated in the regulation of fibroblast proliferation (Otto et al., 1982) . Therefore, ever, measurements in plasma during our experiments using the same dose of ASA showed some it seems rational to link the effects of ASA therapy to its anti-inflammatory action. However, in the interference with prostaglandin synthesis as well, as indicated from a decrease of prostacyclin levels present study, ASA treatment did not affect prostaglandin levels during the inflammatory phase after at those time points that were not associated with the inflammatory response to infarction. This disinfarction. Secondly, fibrosis in the spared myocardium, remote from the infarct, rather than in crepancy could be explained by the fact that the dose of ASA, that selectively inhibits thromboxane the infarcted area itself was affected; scar thinning and scar collagen content were not significantly synthesis, was evaluated in vitro only in those tissues in which the major production was expected altered. On the other hand, inflammation may not be limited to the infarcted area itself (Sulpice et different control mechanisms. Corday et al. (1975) pointed out that in dogs, in an experimental model al., 1994). The observation that at 8 days after infarction, when cardiac edema is known to be over of myocardial infarction, replacement fibrosis was not limited to the infarcted area, but was also its maximum (Fishbein et al., 1978) , increased tissue water content was more pronounced with present in areas remote from the infarct, as a result of focal necrosis. Because we have not observed ASA therapy, suggests still some interference with local inflammatory response to infarction. Other focal necrosis in the sections of spared myocardium analysed for fibrosis in the rat coronary artery possibilities include a role for thromboxane, direct or indirect in the prevention of release of plateletligation model, this indicates that we indeed quantified interstitial fibrosis in non-infarcted areas, and derived growth factor (Vissinger et al., 1993; Lanas et al., 1994) . Finally, effects of medication unrelated that replacement fibrosis could be considered limited to the infarcted area itself. to inactivation of cyclo-oxygenase, for example by metabolites of ASA (Haynes et al., 1993) , cannot
In the present study, only total collagen content was measured. Collagen type, cross-linking, fiber be excluded.
Another important aspect of the effect of ASA is organization and fiber thickness could also alter the mechanical properties of the myocardium. We that the prevention of collagen build-up in noninfarcted tissue after infarction did not result in a cannot exclude that not only the quantity, but also the characteristics of the collagen were affected by further increase of left ventricular cavity diameter in a relaxed state. Diastolic pressure-volume curves ASA treatment. For example, ASA treated hearts could have a higher proportion of thin collagen in infarcted hearts were not altered by ASA treatment (data not shown), indicating that also during filaments, as is also suggested by the photomicrographs shown in Figure 1 . distension by pressures that are physiological during diastole, left ventricular dilation was not agSince large myocardial infarction did not decrease heart dry weight to body weight ratios, hypertrophy gravated by ASA treatment. Therefore, it is likely that ASA treatment did not aggravate the initial of spared myocardium is indicated. Although we have not actually measured myocyte dimensions, process of breakdown of pre-existing collagen fibres correlating with post-infarct dilation (Whittaker et comparable heart dry weights make it unlikely that ASA treatment would reduce cardiomyocyte al., 1991). Likewise, the slightly lower collagen content of the infarcted tissue did not result in hypertrophy in addition to collagen content, as is the case with ACE-inhibitor and angiotensin II further thinning of this area, which has been described with steroids and NSAIDs (Brown et al., blocker therapy (van Krimpen et al., 1991; Smits et al., 1992) . There was no significant effect of ASA 1983; Hammerman et al., 1983a,b; Mannisi et al., 1987) . An effect of ASA treatment on interstitial therapy on in vitro left ventricular performance. If anything, there may be a tendency to delay the fibrosis of spared myocardium, but not on replacement fibrosis of infarcted tissue, suggests that onset of left ventricular dysfunction. After ASA treatment, the significant depression of peak these are indeed two different processes governed by fibrosis at 14 days makes it unlikely that the treatment effect would be absent at the other time points during the healing period. Moreover, retardation of the healing period by ASA, implying a temporary nature of the observed treatment effects, is unlikely because of the lack of effect on collagen deposition in the infarcted area. However, the effect on interstitial fibrosis of remodeled, spared hypertrophic myocardium by ASA treatment, did not result in an altered diastolic pressure-volume relationship of the whole left ventricle (data not shown). Thus, at present, the consequence of pharmacological interference with collagen synthesis during remodeling after infarction, for cardiac function, remain unclear.
In conclusion, the results from the present study show that 25 mg/kg/day ASA, which causes a more marked inhibition of thromboxane than of prostaglandin synthesis in rats, seems pharmacologically equivalent to the use of chronic lowdose aspirin treatment in patients. This dose affected interstitial and perivascular fibrosis in the spared myocardium, while leaving wound healing, measured as scarring and thinning of the infarcted area, and compensatory hypertrophy relatively unaffected. Besides a possible delay in the development, aspirin treatment had no effect on final in vitro left ventricular dysfunction. 
